1
Dey Kaka, Gao Donghong Amy, Goldberg Daniel R, Heim Riether Alexander, Mangette John E, Mugge Ingo Andreas, Snow Roger, Swinamer Alan David, Wu Jiang Ping, Xiong Zhaoming, Yang Yu: Ccr10 antagonists. Boehringer Ingelheim International, Boehringer Ingelheim Pharma & Co Kg, Dey Kaka, Gao Donghong Amy, Goldberg Daniel R, Heim Riether Alexander, Mangette John E, Mugge Ingo Andreas, Snow Roger, Swinamer Alan David, Wu Jiang Ping, Xiong Zhaoming, Yang Yu, MORRIS Michael P, April 23, 2009: WO/2009/052078 (21 worldwide citation)

The invention relates to a compound of formula (I) or a tautomer thereof or a pharmaceutically acceptable salt thereof, wherein R1 to R11, W, X, Y, Z, and n are as defined herein. The invention also relates to methods of using the compounds of formula (I) and compositions thereof to treat various di ...


2
Mugge Ingo Andreas, Burke Michael Jason, Ralph Mark Stephen, Thomson David S, Hammach Abdelhakim, Kowalski Jennifer A, Bentzien Joerg Martin: Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof. Boehringer Ingelheim International, Boehringer Ingelheim Pharma & Co Kg, Mugge Ingo Andreas, Burke Michael Jason, Ralph Mark Stephen, Thomson David S, Hammach Abdelhakim, Kowalski Jennifer A, Bentzien Joerg Martin, MORRIS Michael P, December 21, 2006: WO/2006/135826 (18 worldwide citation)

Compounds of Formula (IA) and (IB) wherein R¿1?, R¿2?, R¿3?, A, B, C, D, and E are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating diseas ...


3

4

5

6

7

8

9
Cook Brian Nicholas, Eldrup Anne Bettina, Mugge Ingo Andreas, Soleymanzadeh Fariba, Sun Sanxing, Zhang Yunlong: Urotensin ii receptor antagonists. Boehringer Ingelheim International, Boehringer Ingelheim Pharma & Co Kg, Cook Brian Nicholas, Eldrup Anne Bettina, Mugge Ingo Andreas, Soleymanzadeh Fariba, Sun Sanxing, Zhang Yunlong, MORRIS Michael P, November 27, 2008: WO/2008/144268

Compounds of the formula (I) wherein R1, R2, R3, R4, R5, R6, W, and Y are as described herein, or a tautomer, prodrug, solvate, or salt thereof. These compounds are useful as inhibitors of Urotensin II and are thus useful for treating a variety of diseases and disorders that are mediated or sustaine ...


10